KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nio (NIO) Research & Development (2017 - 2025)

Nio has reported Research & Development over the past 9 years, most recently at -$289.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 41.84% year-over-year to -$289.7 million, compared with a TTM value of -$1.5 billion through Dec 2025, up 18.06%, and an annual FY2025 reading of $1.5 billion, down 15.09% over the prior year.
  • Research & Development came in at -$289.7 million for Q4 2025, up from -$335.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of -$104.8 million in Q1 2021 to a low of -$577.1 million in Q4 2022.
  • Median Research & Development over the past 5 years was -$415.2 million (2022), compared with a mean of -$374.1 million.
  • The sharpest move saw Research & Development tumbled 165.2% in 2022, then surged 41.84% in 2025.
  • Over 5 years, Research & Development stood at -$286.9 million in 2021, then crashed by 101.14% to -$577.1 million in 2022, then grew by 3.06% to -$559.5 million in 2023, then increased by 10.97% to -$498.1 million in 2024, then surged by 41.84% to -$289.7 million in 2025.
  • Per Business Quant, the three most recent readings for NIO's Research & Development are -$289.7 million (Q4 2025), -$335.8 million (Q3 2025), and -$419.8 million (Q2 2025).